MTOR and cancer: Therapies, such as dual PI3K/mTOR inhibitors or PI3K inhibitors with controlled FOXO modulation, offer promising avenues to disrupt cancer cell survival mechanisms while minimizing resistance and preserving normal cellular homeostasis16.